Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Alcohol Clin Exp Res. 2017 Mar 27;41(5):955–964. doi: 10.1111/acer.13359

Figure 3.

Figure 3

Oxytocin-induced reduction in binge-like ethanol consumption is blocked by pretreatment with an oxytocin receptor antagonist. Oxytocin (1 mg/kg) reduced ethanol intake in the DID model and this effect was reversed by pretreatment with the oxytocin receptor antagonist L368,889 (10 mg/kg). Values are mean ± s.e.m. (N= 10/group). Significantly differs from the vehicle-saline condition: *** (p< 0.001). Significantly differs from the L368,889-OXT group: ++ (p< 0.01).